Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JA1Z
|
||||
| Former ID |
DIB015262
|
||||
| Drug Name |
TA-6666
|
||||
| Synonyms |
T-6666; 815541
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [547979] | ||
| Company |
GlaxoSmithKline plc
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [549776] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.